about
A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformationMolecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesUnique genomic profile of fibrolamellar hepatocellular carcinoma.DNAJB1-PRKACA is specific for fibrolamellar carcinoma.Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regenerationp62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver CancerBiliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations.Liver masses: a clinical, radiologic, and pathologic perspective.cDNA and amino-acid sequences and organization of the gene encoding the B beta subunit of fibrinogen from Xenopus laevis.Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironmentLiver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis.Integration of extracellular RNA profiling data using metadata, biomedical ontologies and Linked Data technologiesIntegrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.Casting a wider net: improving access to medical literature in developing countries.Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinomaExome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasPathophysiology of variceal bleeding.Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cellsRole for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study.Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer.Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsDevelopment and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigationsLoss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinomaComparison of KRAS mutation analysis and FISH for detecting pancreatobiliary tract cancer in cytology specimens collected during endoscopic retrograde cholangiopancreatographyhSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switchDysregulation of apoptosis as a mechanism of liver disease: an overview.The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism.Metformin does not improve survival in patients with hepatocellular carcinoma.Molecular bioluminescence imaging as a noninvasive tool for monitoring tumor growth and therapeutic response to MRI-guided laser ablation in a rat model of hepatocellular carcinoma.SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.Identification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesisHeat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: in vitro and in vivo studyAssociation of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
P50
Q24314746-64EB33EE-BE80-43DB-A267-23E24D13DF6EQ26745338-D1F6AC34-0286-4C94-99DC-8412A42A9226Q27853116-91DFCA2D-B3E1-46AC-9E50-DC77E0EED1C3Q27853135-880F8EF7-FBC5-43ED-AAE5-1AB987FA62FEQ28512564-4DE3868C-4CBC-40FC-AB61-AAC19BAC3CF7Q29144909-D5416939-CBAE-42FA-9A9D-7D2DAD7E3048Q30241563-7D26DBB9-7789-4BA5-92B5-E68D2E4D6214Q30403670-CEE8747A-C5E1-45CB-80DD-F4DD5BFCCD0AQ30417556-D79A723D-431C-4561-8089-774A8AE84DD5Q30450729-51ACC328-A1B8-42A2-A381-B886A8ECAFE1Q30470829-969EA659-3C86-4A4A-B276-031E27673864Q30990708-BCAFB48A-D89B-4D6D-85A4-0B283AD83DF4Q32173000-9694EA3C-F6D3-48BB-8B3F-454E876E06E9Q33286481-6FF82684-55CA-4BC2-A3FA-2CC4AA9ECF08Q33289703-15B04765-C5B0-44CD-A87A-45818A9FC3B3Q33391833-FBCC1262-E979-4DF7-A3B6-ED8AAF813F92Q33581027-2C32A828-220F-434D-9DCE-F9C30FFABB57Q33638521-21B905C9-FE73-475F-913B-B0F05E52AF27Q33869744-11C49231-EEA0-4EC2-AEB5-57F2E58D5665Q33940830-DCB62549-B8FA-4DD7-8406-5FDDEBBD7188Q33955013-29982A63-1161-49ED-B581-C9C23CD3AC24Q34044638-B4520E47-987E-4F2C-9566-5D28D8D41CABQ34104493-099C7D39-572B-4A59-80AA-61BD98CA1884Q34134852-5DEB6AC4-7B22-49BB-B685-A83CC694B39EQ34189632-CEEAE9D2-C8D3-409E-A82A-F08A881C8152Q34219872-A63B148C-3E5E-4383-A8F0-4F4F0C8B9E07Q34239695-949248D3-6469-4D4F-B09F-331D4CD14C1CQ34286925-7BDFF77A-035F-4FA8-BBCA-F50AE2FD4549Q34299789-8D807269-055B-403C-9B15-E60BD11A3CDFQ34460281-D46204E8-4D0A-4760-BEEF-08E930DCBBCEQ34470023-BD311141-9401-4535-9C6F-37BC8F221496Q34490202-41473459-CFAD-4CF2-9F2C-01A1EEC80F7FQ34499122-15A888CA-AB91-4C9B-8A57-4A93694F1E5AQ34521354-61EB493E-D881-411F-9D29-1091028ADF87Q34536227-220573D8-86D8-4687-ACE7-48A1DC2814C0Q34619389-35C2A0B3-0CD1-454D-98E1-495E82B8023EQ34672049-5150DB4A-4017-4463-9147-B6323FEAD1C8Q34722346-A1F037D4-5D72-4C32-A74D-7D2ACC2FC62EQ34742406-B819471C-0FED-4E65-BBC3-7DA7B346F5F7Q35141906-74BB5709-E748-4A13-9792-683B70181138
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lewis R. Roberts
@ast
Lewis R. Roberts
@en
Lewis R. Roberts
@es
Lewis R. Roberts
@nl
Lewis R. Roberts
@sl
type
label
Lewis R. Roberts
@ast
Lewis R. Roberts
@en
Lewis R. Roberts
@es
Lewis R. Roberts
@nl
Lewis R. Roberts
@sl
altLabel
Lewis R Roberts
@en
prefLabel
Lewis R. Roberts
@ast
Lewis R. Roberts
@en
Lewis R. Roberts
@es
Lewis R. Roberts
@nl
Lewis R. Roberts
@sl
P108
P106
P108
P1153
7401560620
P21
P31
P496
0000-0001-7885-8574